153 related articles for article (PubMed ID: 27438231)
1. Intravitreal Dexamethasone for the Treatment of CMO Associated with Refractory Sclerouveitis.
Pohlmann D; Winterhalter S; Pleyer U
Ocul Immunol Inflamm; 2018; 26(1):160-165. PubMed ID: 27438231
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal dexamethasone implants for non-infectious uveitis.
McCartney M; McCluskey P; Zagora S
Clin Exp Ophthalmol; 2019 Dec; 47(9):1156-1163. PubMed ID: 31412151
[TBL] [Abstract][Full Text] [Related]
3. Sustained-release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis.
Pichi F; Nucci P; Baynes K; Lowder CY; Srivastava SK
Int Ophthalmol; 2017 Feb; 37(1):221-228. PubMed ID: 27221263
[TBL] [Abstract][Full Text] [Related]
4. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone Inserts in Noninfectious Uveitis: A Single-Center Experience.
Pohlmann D; Vom Brocke GA; Winterhalter S; Steurer T; Thees S; Pleyer U
Ophthalmology; 2018 Jul; 125(7):1088-1099. PubMed ID: 29459041
[TBL] [Abstract][Full Text] [Related]
6. Spectral domain optical coherence tomography changes following intravitreal dexamethasone implant, Ozurdex® in patients with uveitic cystoid macular edema.
Bansal P; Agarwal A; Gupta V; Singh R; Gupta A
Indian J Ophthalmol; 2015 May; 63(5):416-22. PubMed ID: 26139803
[TBL] [Abstract][Full Text] [Related]
7. [Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital].
Bernard Y; Bonnin N; Farguette F; Chiambaretta F
J Fr Ophtalmol; 2016 Jan; 39(1):1-4. PubMed ID: 26616298
[TBL] [Abstract][Full Text] [Related]
8. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.
Khurana RN; Porco TC
Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone Intravitreal Implant in the Treatment of Uveitic Macular Edema in the Perioperative Cataract Setting: A Case Series.
Larochelle MB; Smith J; Dacey MS
Am J Ophthalmol; 2016 Jun; 166():149-153. PubMed ID: 27066725
[TBL] [Abstract][Full Text] [Related]
10. SAFETY AND EFFICACY OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN THE MANAGEMENT OF MACULAR EDEMA SECONDARY TO INFECTIOUS UVEITIS.
Fonollosa A; Llorenç V; Artaraz J; Jimenez B; Ruiz-Arruza I; Agirrebengoa K; Cordero-Coma M; Costales-Mier F; Adan A
Retina; 2016 Sep; 36(9):1778-85. PubMed ID: 27183031
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal dexamethasone implants for the treatment of refractory scleritis combined with uveitis in adult-onset Still's disease: a case report.
Ahn SJ; Hwang SJ; Lee BR
BMC Ophthalmol; 2016 Nov; 16(1):196. PubMed ID: 27825329
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.
Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J
Retina; 2013; 33(7):1435-40. PubMed ID: 23514796
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal Dexamethasone Implant for Treatment of Sarcoidosis-Related Uveitis.
Kim M; Kim SA; Park W; Kim RY; Park YH
Adv Ther; 2019 Aug; 36(8):2137-2146. PubMed ID: 31140122
[TBL] [Abstract][Full Text] [Related]
14. PROSPECTIVE EVALUATION OF A SUSTAINED-RELEASE DEXAMETHASONE INTRAVITREAL IMPLANT FOR CYSTOID MACULAR EDEMA IN QUIESCENT UVEITIS.
Khurana RN; Bansal AS; Chang LK; Palmer JD; Wu C; Wieland MR
Retina; 2017 Sep; 37(9):1692-1699. PubMed ID: 27893624
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant.
Nobre-Cardoso J; Champion E; Darugar A; Fel A; Lehoang P; Bodaghi B
Ocul Immunol Inflamm; 2017 Aug; 25(4):447-454. PubMed ID: 27003221
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of dexamethasone intravitreal implant for refractory macular edema in children.
Lei S; Lam WC
Can J Ophthalmol; 2015 Jun; 50(3):236-41. PubMed ID: 26040225
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone intravitreal implant for treatment of patients with recalcitrant macular edema resulting from Irvine-Gass syndrome.
Dutra Medeiros M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3320-4. PubMed ID: 23599334
[TBL] [Abstract][Full Text] [Related]
18. Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema.
Scaramuzzi M; Querques G; Spina CL; Lattanzio R; Bandello F
Retina; 2015 Jun; 35(6):1216-22. PubMed ID: 25574787
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal Sustained-Release Steroid Implants for the Treatment of Macular Edema following Surgical Removal of Epiretinal Membranes.
Hattenbach LO; Springer-Wanner C; Hoerauf H; Callizo J; Jungmann S; Brauns T; Fulle G; Eichel S; Koss MJ; Kuhli-Hattenbach C
Ophthalmologica; 2017; 237(4):232-237. PubMed ID: 28463851
[TBL] [Abstract][Full Text] [Related]
20. INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group.
Alshahrani ST; Dolz-Marco R; Gallego-Pinazo R; Diaz-Llopis M; Arevalo JF;
Retina; 2016 Jan; 36(1):131-6. PubMed ID: 26079477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
